New Product Development
The global carrier screening market is expected to record a CAGR of 12.4% between 2023 and 2033, with a size estimated in 2023 at US$ 1,343.40 million. The market’s value is expected to rise to US$ 4,323.84 million by 2033. As a result of increased funding from the public and commercial sectors in response to the rising …
Continue reading “Carrier Screening Market is estimated to yield US$ 1,343.40 million by 2023”
In 2033, the global market for hyaluronic acid personal care products is expected to reach US$ 7.36 billion, up from US$ 3.26 billion in 2023. This market is expected to register an 8.5% CAGR over the next few years, due to growing concerns about the appearance of aging populations. It is easy to purchase these products online …
The global Head and Neck Cancer (HNC) Therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion as they are less …
The Coronavirus Immunoassay Market was worth US$3.7 Billion in 2021. By 2032, the market is anticipated to reach a value of approximately US$ 6.9 Billion, with sales increasing at a 5.5% CAGR throughout the assessment period. With an estimated 64.0% market share in 2021, immunoassay kits & reagents are in the lead. COVID-19 has a …
Immunostimulants Market is expected to have a rise in demand on a global scale from 2022 to 2032, growing at a 6.2% CAGR and reaching about US$ 108.2 billion in 2022. Vaccines will account for more than 62% of the global immunostimulants market in 2021, according to a recent study by Future Market Insights (FMI). …
As per Future Market Insights’ latest industry analysis, the valuation for the global Anti-Adhesion Barrier Gels Market is estimated to be around US$ 93.4 Million in 2022 and is projected to exhibit a CAGR growth of close to 8.4% over the forecast period, with an estimated valuation of US$ 209.8 Million in 2032. An adhesion …
A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can …
The global Difficile Infections (Clostridium Difficile Associated Disease) Treatment market is expected to exceed an impressive valuation of US$ 809 Million in 2023, with a compound annual growth rate (CAGR) of 6% from 2023 to 2033, to be valued at US$ 1,448.75 Million. Clostridium difficile infection (CDI) is a disease caused by toxic compounds produced …
The global Lumbosacral Radicular Pain Management Market is expected to experience robust growth in the coming years due to several factors, including the increasing prevalence of back pain, advancements in medical technologies, and growing patient awareness about the available treatment options. According to a new market research report published by Future Market insights, the global …
The global Atrophic Vaginitis Treatment Market had a market value of US$ 2.57 billion in 2022 and is expected to reach a market value of US$ 6 billion by 2023, growing at an 8% CAGR from 2023 to 2033. The atrophic vaginitis treatment market is expected to grow significantly in the coming years due to …